Change in indication for cardiac resynchronization therapy?

Area of Science:

• Cardiology
• Electrophysiology
• Heart Failure Management

Background:

• Cardiac resynchronization therapy (CRT) is a standard treatment for heart failure (HF) patients with ventricular conduction delay.
• Indications for CRT have expanded beyond sinus rhythm and advanced HF to include patients with mild-to-moderate HF, atrial fibrillation, and those requiring antibradycardia pacing.
• Patient selection for CRT is critical, with wide QRS complexes (>150 ms) and left bundle branch block morphology showing the most benefit.

Purpose of the Study:

• To provide an overview of current indications for CRT.
• To discuss the evolving role of CRT in heart failure management.
• To guide the decision-making process for CRT device selection.

Main Methods:

• Review of published literature on CRT indications.
• Analysis of European guidelines for pacing and heart failure.
• Synthesis of evidence regarding patient selection and device choice.

Main Results:

• Patients with wide QRS complexes benefit most from CRT; narrow QRS complexes (<130 ms) may be associated with harm.
• No mortality benefit demonstrated for CRT defibrillators over CRT pacers alone in randomized trials.
• Older patients with non-ischemic cardiomyopathy may not benefit significantly from implantable cardioverter-defibrillators.

Conclusions:

• CRT device selection (pacer vs. defibrillator) should be individualized based on therapeutic goals, patient age, cardiac disease, and comorbidities.
• Careful patient selection is paramount for optimizing CRT efficacy and avoiding potential harm.
• Further research is needed to clarify the role of defibrillators in specific patient populations.